0001193125-13-093849.txt : 20130306 0001193125-13-093849.hdr.sgml : 20130306 20130306160629 ACCESSION NUMBER: 0001193125-13-093849 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20130227 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130306 DATE AS OF CHANGE: 20130306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IPC The Hospitalist Company, Inc. CENTRAL INDEX KEY: 0001410471 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 954562058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33930 FILM NUMBER: 13669626 BUSINESS ADDRESS: STREET 1: 4605 LANKERSHIM BLVD., SUITE 617 CITY: NORTH HOLLYWOOD STATE: CA ZIP: 91602 BUSINESS PHONE: 818-766-3502 MAIL ADDRESS: STREET 1: 4605 LANKERSHIM BLVD., SUITE 617 CITY: NORTH HOLLYWOOD STATE: CA ZIP: 91602 8-K 1 d497388d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): February 27, 2013

 

 

IPC THE HOSPITALIST COMPANY, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-33930   No. 95-4562058

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

4605 Lankershim Boulevard, Suite 617

North Hollywood, California

(Address of principal executive offices including Zip Code)

(888) 447-2362

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 6, 2013, IPC the Hospitalist Company, Inc. (the “Company”) announced a promotion and change of title for Kerry E. Weiner, M.D. from Chief Clinical Officer to Chief Medical Officer, effective as of February 27, 2013. Dr. Weiner’s compensation and the terms of his employment remain unchanged with the exception of the change in title and related responsibilities.

Prior to Dr. Weiner’s appointment as Chief Medical Officer, Adam D. Singer, M.D., the Company’s Chief Executive Officer, had served in such role since 2006. Dr. Singer will continue to serve as the Company’s Chief Executive Officer. There were no changes made to Dr. Singer’s compensation as a result of this change.

The Company’s press release announcing these management changes is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 8.01. Other Events.

In accordance with the Company’s Corporate Governance Guidelines, on February 27, 2013, the independent members of the Company’s Board of Directors designated director Thomas P. Cooper, M.D. as the Company’s Lead Director.

9.01. Financial Statements and Exhibits.

 

Exhibit

Number

  

Description

99.1

   Press release dated March 6, 2013.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    IPC THE HOSPITALIST COMPANY, INC.
Date: March 6, 2013     By:  

/s/ Adam D. Singer, M.D.

      Adam D. Singer, M.D.
      Chief Executive Officer


EXHIBIT INDEX

 

Exhibit

Number

  

Description

99.1

   Press release dated March 6, 2013.
EX-99.1 2 d497388dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

Media Contact:

      Investor Contact:

Scott Public Relations

      PondelWilkinson

Elaine Murphy

      Evan Pondel

818.610.0270

      310.279.5980

elaine@scottpublicrelations.com

      epondel@pondel.com

IPC The Hospitalist Company Names

Kerry Weiner, M.D. Chief Medical Officer

Also designates Thomas Cooper, M.D. as board’s lead director

North Hollywood, Calif., March 6, 2013 – IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national physician group practice company, announced today that Kerry Weiner, M.D., has been appointed Chief Medical Officer. In his role, Dr. Weiner is responsible for the ongoing development of leadership skills for IPC’s 1,400 hospitalists. He is also responsible for IPC’s continuing efforts to improve the quality and efficiency of the 350 hospitals and 800 post-acute facilities where IPC practices. Dr. Weiner reports to Adam Singer, M.D., IPC’s chairman and CEO.

Previously, Dr. Weiner was IPC’s Chief Clinical Officer, a position he held since joining the Company in March 2011. In that role, Dr. Weiner made significant contributions, including launching the IPC-UCSF Fellowship Program for Hospitalist Leaders and overseeing the rapid expansion of IPC’s continuum of care initiatives.

Prior to joining IPC, Dr. Weiner was Chief Medical Officer for the Lakeside Medical Organization, a multispecialty group of 130 physicians and an IPA of approximately 700 physicians. A co-founder of Lakeside Medical Group, Dr. Weiner served as president of the integrated medical group for fourteen years. He received his medical degree, masters in public health and bachelor’s degree from the University of California, Los Angeles.

“IPC’s practice model, with its focus on effective care transitions, points the way for the future of inpatient care in this new era of healthcare reform,” says Dr. Weiner. “Building strong hospitalists leaders who can execute on clinical quality and cost reduction initiatives further aligns our providers with inpatient facilities across the care continuum.”

Additionally, IPC has appointed Thomas Cooper, M.D., as lead director of the Company’s Board of Directors. Dr. Cooper has served as an IPC director since 2007. He has been a member of the compensation committee and has served as chairman of IPC’s quality committee since June 2008. Dr. Cooper currently serves as lead director for Kindred Healthcare, Inc. and Hanger, Inc.


“Delivering physician leaders to our client facilities is what IPC is known for, and therefore it is imperative to attract the highest caliber physician leaders to our team,” says Dr. Singer. “With Dr. Weiner as CMO and Dr. Cooper as lead director, this sends a clear message to hospitals and post-acute facilities that we are fully committed to delivering excellent physician leaders who truly understand how to align with the goals of the facilities we serve.”

About IPC the Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading physician group practice company focused on the delivery of hospitalist medicine and related facility-based services. IPC’s physicians and affiliated providers practice in hospitals or other inpatient facilities, including acute, post-acute and long-term care settings. The Company offers its providers the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of patient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

###

GRAPHIC 3 g497388g46b34.jpg GRAPHIC begin 644 g497388g46b34.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`, M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8 M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\? M'Q\?'Q\?'Q\?_\``$0@`.@"/`P$1``(1`0,1`?_$`)8``0`"`P$!`0`````` M```````%!P,$!@@!`@$!``(#`0````````````````(#`00%!A```@$#`P,! M!08#!P4``````0(#``0%$1(&,1,'(5%A(C(407&!D14(0E)BH;%R@B,S0\+2 M4R06$0$``@$#`@4#`P4``````````0(#$3$$005189$2,B%Q%-$B$_"A0E(5 M_]H`#`,!``(1`Q$`/P#U-/<06\+SSR+%#&"TDCD*J@=22?05F(U8M:(C67"9 M3S9PNSD:.W:>_93IN@C^`_)M/S3>*KMPLD+Z=WP6ZS M#J\7R#!Y5`V-OX+L>R*168?>NNHJBV.U=X;V//2_QF)2%06E`H%`H%`H%`H% M`H%`H*H\^W]]%CL791L5L[F25K@#H[1A=BM[AN)KH<"L3,SU<+O=[16L1M*" M\:>*K?.V2YG,NZV#L1:VL9VM*%.A=VZA=1H`*MY/+FL^VN[6[=VR,M???X]( M6G;\"X391'MX:T"(-2SQB0Z#VE]QK0G/>>LNY7@X:[5A2O!/-?"^=^35XECN M$6_Z1,)^UE"L?<"P(6$LD0C`5&VZ#X]=2*C&:\=92GB8I_QKZ+=N_%/!IVWQ MX_Z28>JS6LDD+@^[:VG]E61RLD==5%NVX)VKI]OHSVO'.2XH@8S./>6XZ6>4 M7O>GL6=-L@_$-6)R5MO&GV2KQ\E/C?6/"WZIVRN;R5=MW:FWF'7:PDC/^%QH M?S453,1T;5+3.\:2Y7GO(^1X?)XJ+&36L=I]BVGN16^.^K5$7N;Q)W/F9DV;??0:\WG_`!<+ M*DF)E5FCW++]1`;=W%V+0[)P2ABU._NG1=O36@QIYS;ZI+B3&[,0ZNTDLDBH MT9BM&GVQL#(+CN,AV,H&J^HUH--//-UW[G('&NV)2V6>.S"J)MR[DE!F9U30 M.-1\))'V:T$]'Y3REWQ'D.9M\=%!/B;R*V@621IE$$_9(N[B-`LBI''-W6'V MJO6@UKCS198<"VN6CY"T<,D[Y+%!(HI=HF95AA>69I-@MR)G5BJ$C7K0?B;S MM#;(XO<#-:3B4PQ">ZMTB9D>6.3=,3L0*T/IK\VOI0?&\_8V2ZEM;+"7ES<( MD4D<9*1$[X6FD63N:;&C"$:>NOV4'2X#R/:YD9DQXVZM_P!#A$UX)0HU:1&F MBC3U^(O`%DUZ`,!UH)'FW$K7E&#DQ\K=J=3W+2?37MR@>A/])Z&KL.6<=M6K MS.+&:GMG?HC_`!DUU:8`8#(1&WR>'9H9HCT:-F+1RH?XD8'J/94N3I-O=&TJ MNWZUQ_QV^EJ?UJAO)?.^2\!XK?2Y)8Y'EC\8Q'&<9?.8[5<=;=N>[D5M99I)2?6-6^%0!ZM MN]E!(>=O+N6\:8Z"_MVQ]T]ZXBL<7/'-WW*C664R)(%"("/X.I`H,WCKF7D_ MF'#+?,SVEAAI+P/.+RYBF,*0_P#&(K?N+))\(W-(\BCU^$$>M!H^`/,V6\@R M\AQ^6CM6NL',BQ7]BKI!<0R-(JN$D9RO^UKUZ&@ZWR7Y7X;X]Q8O,_<:W,P; MZ+'0@/2\EY&X4<]DL='C[J.ZDM6[.XQ2[%4]R/?JP'Q[2-3 MZCK0=W>XO'7T"P7=NDT*O%(J,/0-!(LL9_RN@84&P8HR-"@T'0:#V:4#LQ%= MNQ=O330::4'T*H)(`U;YC[?OH/@BB``"*`H(4`#T!Z@4&"[Q>/O&MVNK=)6M M91<6Y8?)*%9-X]^UV'XT&?MQZEMHW'J=!K[*#4Q^&QF.6Z6SMUA^MF>XNB"2 M9)9``SLQ)/0`>X#04&[08W2W5_J)`JM&I'=;0;4ZGXO9Z4U8TC75X\YAE,I^ MX'S/;<;Q$KIP_#LW_L)\H@1@+B[/V;I3HD7NT]]&7K&$\=XMQLI&T5A@\';; M6T("00P)K\7W+Z^TT'E3A^/O_/\`YJN>2Y:)APW!,O;M)-=AA1B;>VTZ;IF! MDE]VH]E!9?[I_*D/%.'?_*8F4)G<[&82D7HUO8_+(VB_*9/]M/Q]E!C\+<8B M\.^&,IRSD$+)E+N']2OK8^CJB+I:VWKT>-P3$TNI-M:1J?3MQZ;BOL'K\U!ZQY?PGB/+K&"PY+CH$MXK*VQA^G;'1*L?8(]=I0=-?F!_BZ MU*U9A73)%M=.B6J*PH%`H%`H%`H%!Q7F7$OLA*7R^425+N^DC4D116X4&&!54 MGXF9SJ2=O30.1_<3RB2ZOL;X4X'$7N+N:-LQVW+/)-(0Z12R$LS'_FF=CKTU M/6@[[A/#^;>*^,7G'.*8"/D=Y5+()X;6,$VENX^0_$%WF,>B+M"K[^M!8?EKA M=US7QYF>-6/3]6 MCN)Y9[Q+FU^EG,CZK(9`[2KI'M73M$^E!8V,PEV;X9;-3),S.-;2XFMM,A!K\,T2/HH+5BT;2V*PF4"@4"@4"@4"@Y_D-]S5([R'`XJVGF[1%C=W-WVT[S+Z&2(1. MVU6]A]?=04[X7\*\VX9RS(GI M]M!=]_@89V::UN)L?='U[]LVW4_UQL&C?\5J=;Z;_53?#$[3-9\D)=2^2<7J MT45ER"W'LUL[G3[M7B/X:5;$8K>-?[M:T\BFT5O'I/Z(JX\O_IS;,WQW(X]A MU)573\&.P&K(XGN^-HE1;NGL^=+5?%\Z\)*Z[+S7^7M+_P!]/PLJ,O>ZZ?LKZJSTY-S7D#2*K MWV1N6`9E&D<:]!J?E1%K>_9BKX0XNF7DY-=[2]*\>Q0Q&#L<9O[GT<"0F3^8 MJNA/YUQ,EO=:9\7LL&+^.D5\(2%06E`H%`H%`H%`H%`H%`H/C*K*58!E/4'U M%"815WQ'B]X2;G$VDK'JQA37\P-:LC+>-IE1?BXK;UCT:J^/^$J01A+34=/] M)34OR+^,H?@X?]83-GC[&RB[5G;Q6T7\D**B_DH%53:9W7TI6L:1&C/6$R@4 ="@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@__]D_ ` end